Table 4.
Predictors of mortality among 11,421 patients
| Mortality | |||
|---|---|---|---|
| Unadjusted | Adjusteda | ||
| HR (95%CI) | HR (95%CI) | ||
| Indigenous status | Indigenous (vs. non-Indigenous) | 1.16 (1.06–1.27) | 1.08 (0.96–1.20) |
| Socio-demographic factors | |||
| Age group (years) | 50 years and over (vs. 20–49 years) | 1.69 (1.58–1.80) | 1.57 (1.45–1.69) |
| Gender | Male (vs. Female) | 1.20 (1.14–1.26) | 1.06 (1.00–1.12) |
| Marital status | No partner (vs. Married/De Facto) | 1.12 (1.07–1.18) | 1.07 (1.01–1.13) |
| Rurality of residence | Outside major city (vs. Major city) | 1.17 (1.12–1.23) | 1.13 (1.07–1.20) |
| Socioeconomic advantage and disadvantage | Q4, Q5 (vs. Q1, Q2, Q3) | 1.16 (1.11–1.22) | 1.04 (0.98–1.10) |
| Presumed aetiology | |||
| Alcohol | 1.33 (1.27–1.40) | 1.06 (0.99–1.14) | |
| Cryptogenic/NALFD/NASH | 0.87 (0.82–0.91) | 0.93 (0.87–0.99) | |
| Chronic HCV/HBV | 0.92 (0.86–0.97) | 0.89 (0.83–0.95) | |
| Comorbidities at index admission | |||
| Charlson comorbidity index | > 0 (at least one comorbidity) vs. 0 (none) | 2.27 (2.16–2.39) | 1.46 (1.36–1.56) |
| Diabetes | 1.40 (1.33–1.49) | n/s | |
| Cancer | 2.79 (2.62–2.96) | 2.59 (2.26–2.97) | |
| Complications of cirrhosis at index admission | |||
| Ascites | 1.81 (1.72–1.90) | 1.47 (1.37–1.57) | |
| Gastrointestinal bleeding | 0.72 (0.68–0.76) | n/s | |
| Hepatocellular carcinoma | 2.42 (2.26–2.58) | 0.93 (0.80–1.08) | |
| Health service use | |||
| Pharmacist | 1.56 (1.46–1.66) | 1.08 (1.00–1.16 | |
| Dietician | 1.64 (1.56–1.73) | 0.95 (0.88–1.02) | |
| Social worker | 1.95 (1.84–2.06) | 1.28 (1.19–1.38) | |
| Occupational therapist | 1.93 (1.80–2.04) | n/s | |
| Physiotherapist | 1.96 (1.86–2.06) | 1.14 (1.07–1.23) | |
| Referral source | Emergency department presentation vs. not | 1.78 (1.69–1.87) | 1.56 (1.46–1.67) |
Hazard ratio (HR); a HRs adjusted for length of stay, year of index admission, and all variables in the table except those marked n/s (variable not selected as a predictor)